Table 1. The 16 TCGA cancer types analyzed in this study.
The numbers of primary tumor and normal samples for which both the MORT RNA expression and the MORT promoter DNA methylation data were available are listed. *DNA methylation data from HumanMethylation27 platform that covers 2 CpGs out of 7 CpGs covered by HumanMethylation450 were used.
| TCGA Cancer Type Name | Abbreviation | Tumor
samples |
Normal
samples |
|---|---|---|---|
| adrenocortical carcinoma | ACC | 79 | 0 |
| cervical squamous cell carcinoma and
endocervical adenocarcinoma |
CESC | 304 | 3 |
| cholangiocarcinoma | CHOL | 36 | 9 |
| esophageal carcinoma | ESCA | 184 | 9 |
| glioblastoma multiforme | GBM | 51 | 1 |
| kidney chromophobe | KICH | 66 | 0 |
| brain lower grade glioma | LGG | 516 | 0 |
| mesothelioma | MESO | 87 | 0 |
| ovarian serous cystadenocarcinoma | OV * | 295 | 0 |
| pheochromocytoma and paraganglioma | PCPG | 179 | 3 |
| sarcoma | SARC | 259 | 0 |
| stomach adenocarcinoma | STAD | 373 | 0 |
| testicular germ cell tumors | TGCT | 150 | 0 |
| thymoma | THYM | 120 | 2 |
| uterine carcinosarcoma | UCS | 57 | 0 |
| uveal melanoma | UVM | 80 | 0 |